Stock SOLTF NXERA PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Nxera Pharma Co., Ltd. OTC Markets

Equities

SOLTF

JP3431300007

Market Closed - OTC Markets
Other stock markets
 17:20:04 20/06/2024 BST 		5-day change 1st Jan Change
9.43 USD -5.70% Intraday chart for Nxera Pharma Co., Ltd. 0.00% -5.70%
06-27 Nxera Pharma Co Achieves Key R&D Milestone in Collaboration with AbbVie; Secures $10 Million Payment MT
06-27 Nxera Pharma Co., Ltd. Receives USD 10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone CI

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Nxera Pharma Appoints Patrick Branch as Head of Business Development for Japan and APAC
CI
Sosei Shareholders Greenlight Name Change, Top Management Appointments
MT
Sosei Group Corporation Appoints Toshihiro Maeda as Chief Operating Officer
CI
Sosei Group Corporation Announces Executive Appointments
CI
Sosei Group Corporation Approves Management Changes
CI
Sosei Group Corporation Approves Executive Changes
CI
Sosei Group Corporation Appoints Chris Cargill to the New Role of Group Chief Operating Officer
CI
Sosei Group Corporation Appoints Hironoshin Nomura, as Senior Vice President Investor Relations and Corporate Strategy
CI
Sosei Group Corporation Appoints Rolf Soderstrom as New Board Director and Promotes Dr. Malcolm Weir to Executive Vice Chairman
CI
Sosei Heptares Announces Management Changes
CI
Sosei : Heptares announces nomination of a third clinical candidate by Pfizer from multi-target drug discovery collaboration
AQ
Sosei Heptares Announces Nomination of a Third Clinical Candidate by Pfizer from Multi-Target Drug Discovery Collaboration
CI
Sosei Group Corporation Announces the Appointment of Mr. Noriaki Nagai as External Director
CI
Sosei Group Corporation Announces Management Changes
CI
Sosei Group Corporation Appoints Chris Cargill as Executive Vice President and Chief Financial Officer
CI
Sosei Group Corporation Announces Executive Changes
CI
Sosei : Notice of Withdrawal of New External Director Nomination
PU
Sosei Group Corporation to Withdraw Nomination of Michael Hayden as A New External Director
CI
Sosei Group Corporation Announces Board Changes
CI
Sosei Group Corporation Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4565 Stock
  4. SOLTF Stock
  5. News Nxera Pharma Co., Ltd.
  6. Insiders